Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection | Zendy

Mark Manak | Zendy; Linda L. Jagodzinski | Zendy; Ashley Shutt | Zendy; Jennifer Malia | Zendy; Mike Leos | Zendy; Jason Ouellette | Zendy; Siriwat Akapirat | Zendy; Donn Colby | Zendy; Nittaya Phanuphak | Zendy; Leigh Anne Eller | Zendy; Merlin L. Robb | Zendy; Mark de Souza | Zendy; Jintanat Ananworanich | Zendy; Sheila A. Peel | Zendy

AI Assistant Blog Pricing

Open Access

Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection

Author(s) -

Mark Manak,

Linda L. Jagodzinski,

Ashley Shutt,

Jennifer Malia,

Mike Leos,

Jason Ouellette,

Siriwat Akapirat,

Donn Colby,

Nittaya Phanuphak,

Leigh Anne Eller,

Merlin L. Robb,

Mark de Souza,

Jintanat Ananworanich,

Sheila A. Peel

Publication year - 2019

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.00757-19

Subject(s) - serology , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , virology , medicine , lentivirus , viral disease , sida , viral load , antibody

Antiretroviral therapy (ART) during acute HIV infection (AHI) interrupts viral dynamics and may delay the emergence of serological markers targeted by current HIV screening and confirmatory assays, thus creating challenges for correctly classifying HIV infection status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog